Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Phreesia, Inc. (NYSE:PHR). In a filing disclosed on September 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Phreesia stock on August 26th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of DoorDash NASDAQ: DASH on 8/28/2026.
- Purchased $15,001 - $50,000 in shares of Quanta Services NYSE: PWR on 8/27/2026.
- Purchased $15,001 - $50,000 in shares of Eaton NYSE: ETN on 8/27/2026.
- Sold $15,001 - $50,000 in shares of NIKE NYSE: NKE on 8/27/2026.
- Purchased $1,001 - $15,000 in shares of Wheaton Precious Metals NYSE: WPM on 8/26/2026.
- Purchased $1,001 - $15,000 in shares of Walmart NASDAQ: WMT on 8/26/2026.
- Purchased $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 8/26/2026.
- Sold $15,001 - $50,000 in shares of Lamar Advertising NASDAQ: LAMR on 8/25/2026.
- Sold $1,001 - $15,000 in shares of Phreesia NYSE: PHR on 8/25/2026.
- Sold $15,001 - $50,000 in shares of Lamar Advertising NASDAQ: LAMR on 8/24/2026.
Phreesia Stock Performance
Shares of PHR opened at $10.34 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.76 and a quick ratio of 1.76. Phreesia, Inc. has a one year low of $7.77 and a one year high of $25.29. The company has a market cap of $641.62 million, a PE ratio of 60.81 and a beta of 0.86. The stock has a 50-day moving average of $11.23 and a 200-day moving average of $10.41.
Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). The business had revenue of $129.46 million during the quarter, compared to the consensus estimate of $129.06 million. Phreesia had a net margin of 2.06% and a return on equity of 5.22%. Phreesia's revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.01 EPS. On average, equities research analysts predict that Phreesia, Inc. will post 0.33 EPS for the current fiscal year.
Hedge Funds Weigh In On Phreesia
Several hedge funds and other institutional investors have recently modified their holdings of PHR. Royal Bank of Canada increased its holdings in Phreesia by 208.8% during the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock valued at $617,000 after purchasing an additional 16,309 shares during the period. AQR Capital Management LLC lifted its holdings in Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock worth $4,090,000 after buying an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock worth $1,599,000 after buying an additional 2,158 shares during the period. NewEdge Advisors LLC increased its position in Phreesia by 262.7% during the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock valued at $395,000 after purchasing an additional 11,181 shares during the period. Finally, Goldman Sachs Group Inc. lifted its holdings in Phreesia by 0.4% in the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after buying an additional 2,402 shares during the period. 92.10% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently commented on PHR shares. Weiss Ratings downgraded shares of Phreesia from a "sell (d+)" rating to a "sell (d)" rating in a report on Friday, September 4th. Needham & Company LLC reiterated a "buy" rating and issued a $14.00 target price on shares of Phreesia in a research report on Monday, August 31st. Truist Financial increased their target price on Phreesia from $11.00 to $12.00 and gave the company a "hold" rating in a research note on Thursday, May 28th. Citigroup restated a "market perform" rating on shares of Phreesia in a research report on Friday, September 4th. Finally, Wall Street Zen lowered Phreesia from a "buy" rating to a "hold" rating in a research note on Saturday, September 5th. Eight investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $14.00.
Check Out Our Latest Stock Analysis on PHR
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Phreesia Company Profile
(
Get Free Report)
Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.